VAVEA RET 400a
Food supplement declared in France, declaration No 2024-6-1419, decision dated 26 June 2024
VAVEA RET 400a (VAVEA) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- VAVEA
- Food business operator placing the product on the market
- CESA DEV LDA
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 1 gelule / jour
- Directions for use
- prise orale avec liquide
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans)
- Objectives stated by the manufacturer (these are not authorised claims)
- Œil / Vision
Declaration 270821, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Acétate de rétinyle | Vitamine A | 3,000 µg d'équivalent rétinol | 800 µg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
déconseillé en cas de prise de rétinoïde et en cas de maladie hépatique
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- VAVEA RET 400a VAVEA, declared in 2025 : different composition: 1 ingredient(s) added, 0 missing
Brand : VAVEA